Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study

Authors: Beverley M Essue, Germaine Wong, Jeremy Chapman, Qiang Li, Stephen Jan

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Chronic kidney disease (CKD) poses a financial burden on patients and their households. This descriptive study measures the prevalence of economic hardship and out-of-pocket costs in an Australian CKD population.

Methods

A cross-sectional study of patients receiving care for CKD (stage III-V) in Western Sydney, Australia using a structured questionnaire. Data collection occurred between November 2010 and April 2011. Multivariate analyses assessed the relationships between economic hardship and individual, household and health system characteristics.

Results

The study included 247 prevalent CKD patients. A mean of AUD$907 per three months was paid out-of-pocket resulting in 71% (n=153) of participants experiencing financial catastrophe (out-of-pocket costs exceeding 10% of household income). Fifty-seven percent (n=140) of households reported economic hardship. The adjusted risk factors that decreased the likelihood of hardship included: home ownership (OR: 0.32, 95% CI: 0.14-0.71), access to financial resources (OR: 0.24, 95% CI: 0.11-0.50) and quality of life (OR: 0.12, 95% CI: 0.02-0.56). The factors that increased the likelihood of hardship included if income was negatively impacted by CKD (OR: 4.80, 95% CI: 2.17-10.62) and concessional status (i.e. receiving government support) (OR: 3.09, 95% CI: 1.38-6.91). Out-of-pocket costs and financial catastrophe were not found to be significantly associated with hardship in this analysis.

Conclusions

This study describes the poorer economic circumstances of households affected by CKD and reinforces the inter-relationships between chronic illness, economic well-being and quality of life for this patient population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Australian Institute of Health and Welfare: Health care expenditure on chronic kidney disease in Australia. 2009, Canberra: AIHW, 117-Cat. no. PHE Australian Institute of Health and Welfare: Health care expenditure on chronic kidney disease in Australia. 2009, Canberra: AIHW, 117-Cat. no. PHE
2.
go back to reference Baboolal K, McEwan P, Sondhi S: The cost of renal dialysis in a UK setting—a multicentre study. Nephrol Dial Transplant. 2008, 23: 1982-1989. 10.1093/ndt/gfm870.CrossRefPubMed Baboolal K, McEwan P, Sondhi S: The cost of renal dialysis in a UK setting—a multicentre study. Nephrol Dial Transplant. 2008, 23: 1982-1989. 10.1093/ndt/gfm870.CrossRefPubMed
3.
go back to reference Zelmer JL: The economic burden of end-stage renal disease in Canada. Kidney Int. 2007, 72: 1122-1129. 10.1038/sj.ki.5002459.CrossRefPubMed Zelmer JL: The economic burden of end-stage renal disease in Canada. Kidney Int. 2007, 72: 1122-1129. 10.1038/sj.ki.5002459.CrossRefPubMed
4.
go back to reference Australian Institute of Health and Welfare: Health expenditure Australia: 2010–11. Health and welfare expenditure series no. 47. Cat. no. HWE 56. 2012, Canberra: AIHW Australian Institute of Health and Welfare: Health expenditure Australia: 2010–11. Health and welfare expenditure series no. 47. Cat. no. HWE 56. 2012, Canberra: AIHW
5.
go back to reference Australian Institute of Health and Welfare: Dialysis and kidney transplantation in Australia: 1991–2010. 2012, Canberra: AIHW, Cat. no. PHE 162 Australian Institute of Health and Welfare: Dialysis and kidney transplantation in Australia: 1991–2010. 2012, Canberra: AIHW, Cat. no. PHE 162
7.
go back to reference Muehrer RJ, Schatell D, Witten B: Factors affecting employment at initiation of dialysis. Clin J Am Soc Nephrol. 2011, 6: 489-496. 10.2215/CJN.02550310.CrossRefPubMedPubMedCentral Muehrer RJ, Schatell D, Witten B: Factors affecting employment at initiation of dialysis. Clin J Am Soc Nephrol. 2011, 6: 489-496. 10.2215/CJN.02550310.CrossRefPubMedPubMedCentral
8.
go back to reference Alexander GC, Casalino LP, Meltzer DO: Patient-physician communication about out-of-pocket costs. JAMA. 2003, 290: 953-958. 10.1001/jama.290.7.953.CrossRefPubMed Alexander GC, Casalino LP, Meltzer DO: Patient-physician communication about out-of-pocket costs. JAMA. 2003, 290: 953-958. 10.1001/jama.290.7.953.CrossRefPubMed
9.
go back to reference Essue B, Kelly P, Roberts M: We can't afford my chronic illness! The out-of-pocket burden associated with managing chronic obstructive pulmonary disease in western Sydney, Australia. J Health Serv Res Pol. 2011, 16: 226-231. 10.1258/jhsrp.2011.010159.CrossRef Essue B, Kelly P, Roberts M: We can't afford my chronic illness! The out-of-pocket burden associated with managing chronic obstructive pulmonary disease in western Sydney, Australia. J Health Serv Res Pol. 2011, 16: 226-231. 10.1258/jhsrp.2011.010159.CrossRef
10.
go back to reference Piette JD, Heisler M, Wagner TH: Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004, 27: 384-391. 10.2337/diacare.27.2.384.CrossRefPubMed Piette JD, Heisler M, Wagner TH: Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004, 27: 384-391. 10.2337/diacare.27.2.384.CrossRefPubMed
11.
go back to reference Jeon Y-H, Essue B, Jan S: Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Heal Serv Res. 2009, 9: 182-10.1186/1472-6963-9-182.CrossRef Jeon Y-H, Essue B, Jan S: Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Heal Serv Res. 2009, 9: 182-10.1186/1472-6963-9-182.CrossRef
12.
go back to reference Jan S, Essue BM, Leeder SR: Falling through the cracks: the hidden economic burden of chronic illness and disability on Australian households. MJA. 2011, 196: 1-3. Jan S, Essue BM, Leeder SR: Falling through the cracks: the hidden economic burden of chronic illness and disability on Australian households. MJA. 2011, 196: 1-3.
13.
go back to reference Hackett ML, Glozier NG, Jan S: Psychosocial Outcomes in StrokE: the POISE observational stroke study protocol. BMC Neurol. 2009, 9: 10.1186/1471-2377-9-24. Hackett ML, Glozier NG, Jan S: Psychosocial Outcomes in StrokE: the POISE observational stroke study protocol. BMC Neurol. 2009, 9: 10.1186/1471-2377-9-24.
14.
go back to reference Hackett ML, Glozier NS, Martiniuk AL: Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol. BMC Neurol. 2011, 11: 10.1186/1471-2377-11-3. Hackett ML, Glozier NS, Martiniuk AL: Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol. BMC Neurol. 2011, 11: 10.1186/1471-2377-11-3.
16.
go back to reference Banks E, Redman S, 45 and Up Study Collaborators: Cohort profile: the 45 and up study. Int J Epidemiol. 2008, 5: 941-947. Banks E, Redman S, 45 and Up Study Collaborators: Cohort profile: the 45 and up study. Int J Epidemiol. 2008, 5: 941-947.
17.
go back to reference Australian Bureau of Statistics: 2010 General Social Survey: Summary results. 2011, Canberra: ABS. Cat no. 4159.0 Australian Bureau of Statistics: 2010 General Social Survey: Summary results. 2011, Canberra: ABS. Cat no. 4159.0
18.
go back to reference Grootaert C, Narayan D, Jones VN: Measuring Social Capital: an integrated questionnaire. Working paper No. 18. 2004, Washington: The World BankCrossRef Grootaert C, Narayan D, Jones VN: Measuring Social Capital: an integrated questionnaire. Working paper No. 18. 2004, Washington: The World BankCrossRef
19.
go back to reference de Vos K, Zaidi MA: Equivalence scale sensitivity of poverty statistics for the member states of the European Community. Review of Income and Wealth. 1997, 43: 319-333. 10.1111/j.1475-4991.1997.tb00222.x.CrossRef de Vos K, Zaidi MA: Equivalence scale sensitivity of poverty statistics for the member states of the European Community. Review of Income and Wealth. 1997, 43: 319-333. 10.1111/j.1475-4991.1997.tb00222.x.CrossRef
20.
go back to reference Berki SE: A look at catastrophic medical expenses and the poor. Health Aff (Millwood). 1986, 5: 138-145. 10.1377/hlthaff.5.4.138.CrossRef Berki SE: A look at catastrophic medical expenses and the poor. Health Aff (Millwood). 1986, 5: 138-145. 10.1377/hlthaff.5.4.138.CrossRef
21.
go back to reference Gordon EJ, Prohaska TR, Sehgal AR: The financial impact of immunosuppressant expenses on new kidney transplant recipients. Clin Transplant. 2008, 22: 738-748. 10.1111/j.1399-0012.2008.00869.x.CrossRefPubMedPubMedCentral Gordon EJ, Prohaska TR, Sehgal AR: The financial impact of immunosuppressant expenses on new kidney transplant recipients. Clin Transplant. 2008, 22: 738-748. 10.1111/j.1399-0012.2008.00869.x.CrossRefPubMedPubMedCentral
22.
go back to reference Schoen C, Osborn R, Squires D: How health insurance design affects access to care and costs, by income in eleven countries. Health Aff. 2010, 29: 2323-2334. 10.1377/hlthaff.2010.0862.CrossRef Schoen C, Osborn R, Squires D: How health insurance design affects access to care and costs, by income in eleven countries. Health Aff. 2010, 29: 2323-2334. 10.1377/hlthaff.2010.0862.CrossRef
23.
go back to reference Hirth RA, Greer SL, Albert JM: Out-Of-Pocket Spending And Medication Adherence Among Dialysis Patients In Twelve Countries. Heal Aff. 2008, 27: 89-102. 10.1377/hlthaff.27.1.89.CrossRef Hirth RA, Greer SL, Albert JM: Out-Of-Pocket Spending And Medication Adherence Among Dialysis Patients In Twelve Countries. Heal Aff. 2008, 27: 89-102. 10.1377/hlthaff.27.1.89.CrossRef
24.
go back to reference Hynd A, Roughead EE, Preen DB: The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiology and Drug Safety. 2008, 17: 1091-1099. 10.1002/pds.1670.CrossRefPubMed Hynd A, Roughead EE, Preen DB: The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiology and Drug Safety. 2008, 17: 1091-1099. 10.1002/pds.1670.CrossRefPubMed
25.
go back to reference Piette JD, Heisler M, Wagner TH: Cost-related medication underuse: do patients with chronic illnesses tell their doctors?. Arch Intern Med. 2004, 164: 1749-1755. 10.1001/archinte.164.16.1749.CrossRefPubMed Piette JD, Heisler M, Wagner TH: Cost-related medication underuse: do patients with chronic illnesses tell their doctors?. Arch Intern Med. 2004, 164: 1749-1755. 10.1001/archinte.164.16.1749.CrossRefPubMed
26.
go back to reference Liem YS, Bosch JL, Myriam Hunink MG: Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008, 11: 733-741. 10.1111/j.1524-4733.2007.00308.x.CrossRefPubMed Liem YS, Bosch JL, Myriam Hunink MG: Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008, 11: 733-741. 10.1111/j.1524-4733.2007.00308.x.CrossRefPubMed
27.
go back to reference Blake C, Codd MB, Cassidy A: Physical function, employment and quality of life in end-stage renal disease. J Nephrol. 2000, 13: 142-149.PubMed Blake C, Codd MB, Cassidy A: Physical function, employment and quality of life in end-stage renal disease. J Nephrol. 2000, 13: 142-149.PubMed
Metadata
Title
How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study
Authors
Beverley M Essue
Germaine Wong
Jeremy Chapman
Qiang Li
Stephen Jan
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-5

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.